ApoE and outcome after traumatic brain injury

References

• Laskowitz DT, McKenna SE, Song P et al. COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury. J. Neurotrauma 24, 1093–1107 (2007).
   Google Scholar
• Ferguson S, Mouzon B, Kayihan G et al. Apolipoprotein E genotype and oxidative stress response to traumatic brain injury. Neuroscience 168, 811–819 (2010).
   Google Scholar
• Mori T, Town T, Kobayashi M, Tan J, Fujita SC, Asano T. Augmented delayed infarct expansion and reactive astrocytosis after permanent focal ischemia in apolipoprotein E4 knock-in mice. J. Cereb. Blood Flow Metab. 24, 646–656 (2004).
   Google Scholar
• Bu G. Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 10, 333–344 (2009).
   Google Scholar
• Laskowitz DT, Vitek MP. Apolipoprotein E and neurological disease: therapeutic potential and pharmacogenomic interactions. Pharmacogenomics 8, 959–969 (2007). ▪▪ Addresses data and potential mechanisms for isoform‑specific effects of APOE and recovery from acute brain injury.
   Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923 (1993).
   Google Scholar
• Montine TJ, Montine KS, Olson SJ et al. Increased cerebral cortical lipid peroxidation and abnormal phospholipids in aged homozygous apoE-deficient C57BL/6J mice. Exp. Neurol. 158, 234–241 (1999).
   Google Scholar
• Linton MF, Gish R, Hubl ST et al. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88, 270–281 (1991).
   Google Scholar
• Sabo T, Lomnitski L, Nyska A et al. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience 101, 879–884 (2000).
   Google Scholar
• Bennett RE, Esparza TJ, Lewis HA et al. Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-b immunoreactivity after traumatic brain injury in 3xTG-AD mice. J. Neuropathol. Exp. Neurol. 72, 396–403 (2013).
   Google Scholar
• Hartman RE, Laurer H, Longhi L et al. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer’s disease. J. Neurosci. 22, 10083–10087 (2002).
   Google Scholar
• Nicoll JA, Roberts GW, Graham DI. Apolipoprotein E e 4 allele is associated with deposition of amyloid b-protein following head injury. Nat. Med. 1, 135–137 (1995).
   Google Scholar
• Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350, 1069–1071 (1997).
   Google Scholar
• Friedman G, Froom P, Sazbon L et al. Apolipoprotein E-e4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 52, 244–248 (1999).
   Google Scholar
• Lichtman SW, Seliger G, Tycko B, Marder K. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 55, 1536–1539 (2000).
   Google Scholar
• Crawford FC, Vanderploeg RD, Freeman MJ et al. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 58, 1115–1118 (2002).
   Google Scholar
• Muller K, Ingebrigtsen T, Wilsgaard T et al. Prediction of time trends in recovery of cognitive function after mild head injury. Neurosurgery 64, 698–704 (2009).
   Google Scholar
• Noe E, Ferri J, Colomer C, Moliner B, Chirivella J. APOE genotype and verbal memory recovery during and after emergence from post-traumatic amnesia. Brain Inj. 24, 886–892 (2010).
   Google Scholar
• Ponsford J, McLaren A, Schonberger M et al. The association between apolipoprotein E and traumatic brain injury severity and functional outcome in a rehabilitation sample. J. Neurotrauma 28, 1683–1692 (2011).
   Google Scholar
• Pruthi N, Chandramouli BA, Kuttappa TB et al. Apolipoprotein E polymorphism and outcome after mild to moderate traumatic brain injury: a study of patient population in India. Neurol. Ind. 58, 264–269 (2010).
   Google Scholar
• Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J. Neurotrauma 25, 279–290 (2008).
   Google Scholar
• Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S. Apolipoprotein E e4 associated with chronic traumatic brain injury in boxing. JAMA 278, 136–140 (1997).
   Google Scholar
• Kutner KC, Erlanger DM, Tsai J, Jordan B, Relkin NR. Lower cognitive performance of older football players possessing apolipoprotein E e4. Neurosurgery 47, 651–657; discussion 657–658 (2000).
   Google Scholar
• Liberman JN, Stewart WF, Wesnes K, Troncoso J. Apolipoprotein E e4 and shortterm recovery from predominantly mild brain injury. Neurology 58, 1038–1044 (2002).
   Google Scholar
• Isoniemi H, Kurki T, Tenovuo O, Kairisto V, Portin R. Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injury. Neurology 67, 756–760 (2006).
   Google Scholar
• Isoniemi H, Tenovuo O, Portin R, Himanen L, Kairisto V. Outcome of traumatic brain injury after three decades – relationship to ApoE genotype. J. Neurotrauma 23, 1600–1608 (2006).
   Google Scholar
• Rapoport M, Wolf U, Herrmann N et al. Traumatic brain injury, Apolipoprotein E-e4, and cognition in older adults: a twoyear longitudinal study. J. Neuropsychiatry Clin. Neurosci. 20, 68–73 (2008).
   Google Scholar
• Hiekkanen H, Kurki T, Brandstack N, Kairisto V, Tenovuo O. Association of injury severity, MRI-results and ApoE genotype with 1-year outcome in mainly mild TBI: a preliminary study. Brain Inj. 23, 396–402 (2009).
   Google Scholar
• Shadli RM, Pieter MS, Yaacob MJ, Rashid FA. APOE genotype and neuropsychological outcome in mild-to-moderate traumatic brain injury: a pilot study. Brain Inj. 25, 596–603 (2011).
   Google Scholar
• Liaquat I, Dunn LT, Nicoll JA, Teasdale GM, Norrie JD. Effect of apolipoprotein E genotype on hematoma volume after trauma. J. Neurosurg. 96, 90–96 (2002).
   Google Scholar
• Chiang MF, Chang JG, Hu CJ. Association between apolipoprotein E genotype and outcome of traumatic brain injury. Acta Neurochirurgica 145, 649–653; discussion 53–54 (2003).
   Google Scholar
• Jiang Y, Sun X, Xia Y, Tang W, Cao Y, Gu Y. Effect of APOE polymorphisms on early responses to traumatic brain injury. Neurosci. Lett. 408, 155–158 (2006).
   Google Scholar
• Alberts MJ, Graffagnino C, McClenny C et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet 346, 575 (1995).
   Google Scholar
• McCarron MO, Weir CJ, Muir KW et al. Effect of apolipoprotein E genotype on inhospital mortality following intracerebral haemorrhage. Acta Neurol. Scand. 107, 106–109 (2003).
   Google Scholar
• James ML, Blessing R, Bennett E, Laskowitz DT. Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humans. J. Stroke Cerebrovasc. Dis. 18, 144–149 (2009).
   Google Scholar
• Lanterna LA, Biroli F. Significance of apolipoprotein E in subarachnoid hemorrhage: neuronal injury, repair, and therapeutic perspectives – a review. J. Stroke Cerebrovasc. Dis. 18, 116–123 (2009).
   Google Scholar
• Mannix RC, Zhang J, Park J et al. Agedependent effect of apolipoprotein E4 on functional outcome after controlled cortical impact in mice. J. Cereb. Blood Flow Metab. 31, 351–361 (2011).
   Google Scholar
• Brichtova E, Kozak L. Apolipoprotein E genotype and traumatic brain injury in children – association with neurological outcome. Child’s Nerv. Syst. 24, 349–356 (2008).
   Google Scholar
• Moran LM, Taylor HG, Ganesalingam K et al. Apolipoprotein E4 as a predictor of outcomes in pediatric mild traumatic brain injury. J. Neurotrauma 26, 1489–1495 (2009).
   Google Scholar
• Quinn TJ, Smith C, Murray L, Stewart J, Nicoll JA, Graham DI. There is no evidence of an association in children and teenagers between the apolipoprotein E e4 allele and post-traumatic brain swelling. Neuropathol. Appl. Neurobiol. 30, 569–575 (2004).
   Google Scholar
• Colton CA, Brown CM, Vitek MP. Sex steroids, APOE genotype and the innate immune system. Neurobiol. Aging 26, 363–372 (2005).
   Google Scholar
• Gromadzka G, Baranska-Gieruszczak M, Sarzynska-Dlugosz I, Ciesielska A, Czlonkowska A. The APOE polymorphism and 1-year outcome in ischemic stroke: genotype–gender interaction. Acta Neurol. Scand. 116, 392–398 (2007).
   Google Scholar
• Ost M, Nylen K, Csajbok L, Blennow K, Rosengren L, Nellgard B. Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury. Acta Anaesthesiol. Scand. 52, 1364–1369 (2008).
   Google Scholar
• Struble RG, Cady C, Nathan BP, McAsey M. Apolipoprotein E may be a critical factor in hormone therapy neuroprotection. Front. Biosci. 13, 5387–5405 (2008).
   Google Scholar
• Nathan BP, Barsukova AG, Shen F, McAsey M, Struble RG. Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology 145, 3065–3073 (2004).
   Google Scholar
• Cheng X, McAsey ME, Li M et al. Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain. Neurosci. Lett. 417, 50–54 (2007).
   Google Scholar
• Struble RG, Nathan BP, Cady C, Cheng X, McAsey M. Estradiol regulation of astroglia and apolipoprotein E: an important role in neuronal regeneration. Exp. Gerontol. 42, 54–63 (2007).
   Google Scholar
• Ramlackhansingh AF, Brooks DJ, Greenwood RJ et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann. Neurol. 70, 374–383 (2011).
   Google Scholar
• Jacobowitz DM, Cole JT, McDaniel DP, Pollard HB, Watson WD. Microglia activation along the corticospinal tract following traumatic brain injury in the rat: a neuroanatomical study. Brain Res. 1465, 80–89 (2012).
   Google Scholar
• Jin X, Ishii H, Bai Z, Itokazu T, Yamashita T. Temporal changes in cell marker expression and cellular infiltration in a controlled cortical impact model in adult male C57BL/6 mice. PLoS ONE e41892 (2012).
   Google Scholar
• Hernandez-Ontiveros DG, Tajiri N, Acosta S, Giunta B, Tan J, Borlongan CV. Microglia activation as a biomarker for traumatic brain injury. Front. Neurol. 4, 30 (2013).
   Google Scholar
• Khovidhunkit W, Kim MS, Memon RA et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45, 1169–1196 (2004).
   Google Scholar
• Wang Y, Zhu X, Wu G, Shen L, Chen B. Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mice. J. Lipid Res. 49, 1640–1645 (2008).
   Google Scholar
• Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM. Anti-inflammatory properties of HDL. Rev. Endocrine Metab. Disord. 5, 351–358 (2004).
   Google Scholar
• Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ. Res. 95, 764–772 (2004).
   Google Scholar
• Harris HW, Grunfeld C, Feingold KR, Rapp JH. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86, 696–702 (1990).
   Google Scholar
• Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl Acad. Sci. USA 90, 12040–12044 (1993).
   Google Scholar
• Chuang K, Elford EL, Tseng J, Leung B, Harris HW. An expanding role for apolipoprotein E in sepsis and inflammation. Am. J. Surg. 200, 391–397 (2010).
   Google Scholar
• Laskowitz DT, Lee DM, Schmechel D, Staats HF. Altered immune responses in apolipoprotein E-deficient mice. J. Lipid Res. 41, 613–620 (2000).
   Google Scholar
• Lynch JR, Tang W, Wang H et al. APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 278, 48529–48533 (2003).
   Google Scholar
• de Bont N, Netea MG, Demacker PN et al. Apolipoprotein E knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 40, 680–685 (1999).
   Google Scholar
• Van Oosten M, Rensen PC, Van Amersfoort ES et al. Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J. Biol. Chem. 276, 8820–8824 (2001).
   Google Scholar
• Roselaar SE, Daugherty A. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenesin vivo. J. Lipid Res. 39, 1740–1743 (1998).
   Google Scholar
• Moretti EW, Morris RW, Podgoreanu M et al. APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit. Care Med. 33, 2521–2526 (2005).
   Google Scholar
• Ely EW, Girard TD, Shintani AK et al. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit. Care Med. 35, 112–117 (2007).
   Google Scholar
• Laskowitz DT, Goel S, Bennett ER, Matthew WD. Apolipoprotein E suppresses glial cell secretion of TNFa. J. Neuroimmunol. 76, 70–74 (1997).
   Google Scholar
• Barger SW, Harmon AD. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878–881 (1997). ▪ First manuscript to address isoform‑specific effects of apoE on microglial activation.
   Google Scholar
• Laskowitz DT, Thekdi AD, Thekdi SD et al. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp. Neurol. 167, 74–85 (2001). ▪▪ First manuscript to address the therapeutic strategy of creating apoE mimetic peptides to reduce neuroinflammatory responses.
   Google Scholar
• Lynch JR, Pineda JA, Morgan D et al. Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann. Neurol. 51, 113–117 (2002). ▪▪ Initial observation that endogenous apoE modifies neuroinflammatory responses and development of cerebral edema in an in vivo model of traumatic brain injury.
   Google Scholar
• Ophir G, Meilin S, Efrati M et al. Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice. Neurobiol. Dis. 12, 56–64 (2003).
   Google Scholar
• James ML, Sullivan PM, Lascola CD, Vitek MP, Laskowitz DT. Pharmacogenomic effects of apolipoprotein E on intracerebral hemorrhage. Stroke 40, 632–639 (2009).
   Google Scholar
• Gao J, Wang H, Sheng H et al. A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit. Care 4, 25–31 (2006).
   Google Scholar
• Beffert U, Nematollah Farsian F, Masiulis I et al. ApoE receptor 2 controls neuronal survival in the adult brain. Curr. Biol. 16, 2446–2452 (2006).
   Google Scholar
• Gajera CR, Emich H, Lioubinski O et al. LRP2 in ependymal cells regulates BMP signaling in the adult neurogenic niche. J. Cell Sci. 123, 1922–1930 (2010).
   Google Scholar
• Beffert U, Weeber EJ, Durudas A et al. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor apoER2. Neuron 47, 567–579 (2005).
   Google Scholar
• Niu S, Yabut O, D’Arcangelo G. The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons. J. Neurosci. 28, 10339–10348 (2008).
   Google Scholar
• Zhuo M, Holtzman DM, Li Y et al. Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J. Neurosci. 20, 542–549 (2000).
   Google Scholar
• Sinagra M, Verrier D, Frankova D et al. Reelin, very-low-density lipoprotein receptor, and apolipoprotein E receptor 2 control somatic NMDA receptor composition during hippocampal maturation in vitro. J. Neurosci. 25, 6127–6136 (2005).
   Google Scholar
• Herz J, Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 7, 850–859 (2006).
   Google Scholar
• Christie RH, Chung H, Rebeck GW, Strickland D, Hyman BT. Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer’s disease. J. Neuropathol. Exp. Neurol. 55, 491–498 (1996).
   Google Scholar
• Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron 11, 575–580 (1993).
   Google Scholar
• Hoe HS, Harris DC, Rebeck GW. Multiple pathways of apolipoprotein E signaling in primary neurons. J. Neurochem. 93, 145–155 (2005).
   Google Scholar
• Misra UK, Adlakha CL, Gawdi G, McMillian MK, Pizzo SV, Laskowitz DT. Apolipoprotein E and mimetic peptide initiate a calciumdependent signaling response in macrophages. J. Leukocyte Biol. 70, 677–683 (2001).
   Google Scholar
• Pocivavsek A, Burns MP, Rebeck GW. Low-density lipoprotein receptors regulate microglial inflammation through c-Jun in situ N-terminal kinase. Glia 57, 444–453 (2009).
   Google Scholar
• Hidding U, Mielke K, Waetzig V et al. The c-Jun in situ N-terminal kinases in cerebral microglia: immunological functions in the brain. Biochem. Pharmacol. 64, 781–788 (2002).
   Google Scholar
• Pocivavsek A, Mikhailenko I, Strickland DK, Rebeck GW. Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun in situ N-terminal kinase activation. J. Neuroimmunol. 214, 25–32 (2009). ▪▪ Describes the role of apoE binding to microglial LRP1 receptors to initiate intracellular signaling and downregulate inflammation.
   Google Scholar
• Bell RD, Winkler EA, Singh I et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512–516 (2012).
   Google Scholar
• Maezawa I, Maeda N, Montine TJ, Montine KS. Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice. J. Neuroinflammation 3, 10 (2006).
   Google Scholar
• Ophir G, Amariglio N, Jacob-Hirsch J, Elkon R, Rechavi G, Michaelson DM. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kB signaling cascade. Neurobiol. Dis. 20, 709–718 (2005).
   Google Scholar
• Kosacka J, Gericke M, Nowicki M, Kacza J, Borlak J, Spanel-Borowski K. Apolipoproteins D and E3 exert neurotrophic and synaptogenic effects in dorsal root ganglion cell cultures. Neuroscience 162, 282–291 (2009).
   Google Scholar
• Qiu Z, Hyman BT, Rebeck GW. Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons. J. Biol. Chem. 279, 34948–34956 (2004).
   Google Scholar
• Nathan BP, Jiang Y, Wong GK, Shen F, Brewer GJ, Struble RG. Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein. Brain Res. 928, 96–105 (2002).
   Google Scholar
• Hack I, Hellwig S, Junghans D et al. Divergent roles of ApoER2 and VLDLR in the migration of cortical neurons. Development 134, 3883–3891 (2007).
   Google Scholar
• Beffert U, Stolt PC, Herz J. Functions of lipoprotein receptors in neurons. J. Lipid Res. 45, 403–409 (2004).
   Google Scholar
• Hoe HS, Rebeck GW. Functional interactions of APP with the apoE receptor family. J. Neurochem. 106, 2263–2271 (2008).
   Google Scholar
• Ohkubo N, Mitsuda N, Tamatani M et al. Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signalregulated kinase pathway. J. Biol. Chem. 276, 3046–3053 (2001).
   Google Scholar
• Qiu D, Mao L, Kikuchi S, Tomita M. Sustained MAPK activation is dependent on continual NGF receptor regeneration. Dev. Growth Different. 46, 393–403 (2004).
   Google Scholar
• Li YS, Matsunaga K, Kato R, Ohizumi Y. Potentiation of nerve growth factor-induced elongation of neurites by gelsemiol and 9-hydroxysemperoside aglucone in PC12D cells. J. Pharm. Pharmacol. 53, 915–919 (2001).
   Google Scholar
• Aono M, Bennett ER, Kim KS et al. Protective effect of apolipoprotein E-mimetic peptides on in situ N-methyl-d-aspartate excitotoxicity in primary rat neuronal–glial cell cultures. Neuroscience 116, 437–445 (2003).
   Google Scholar
• Aono M, Lee Y, Grant ER et al. Apolipoprotein E protects against NMDA excitotoxicity. Neurobiol. Dis. 11, 214–220 (2002).
   Google Scholar
• Chen Y, Durakoglugil MS, Xian X, Herz J. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing apoE receptor recycling. Proc. Natl Acad. Sci. USA 107, 12011–12016 (2010).
   Google Scholar
• Hoe HS, Pocivavsek A, Chakraborty G et al. Apolipoprotein E receptor 2 interactions with the in situ N-methyl-d-aspartate receptor. J. Biol. Chem. 281, 3425–3431 (2006). ▪ Describes apoE receptor modulation of N‑methyl‑d‑aspartate receptor function.
   Google Scholar
• Martin AM, Kuhlmann C, Trossbach S et al. The functional role of the second NPXY motif of the LRP1 b-chain in tissue-type plasminogen activator-mediated activation of in situ N-methyl-d-aspartate receptors. J. Biol. Chem. 283, 12004–12013 (2008).
   Google Scholar
• Sheng Z, Prorok M, Brown BE, Castellino FJ. in situ N-methyl-d-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein. Neuropharmacology 55, 204–214 (2008).
   Google Scholar
• Qiu Z, Crutcher KA, Hyman BT, Rebeck GW. ApoE isoforms affect neuronal in situ N-methyl-d-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience 122, 291–303 (2003).
   Google Scholar
• Lynch JR, Morgan D, Mance J, Matthew WD, Laskowitz DT. Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J. Neuroimmunol. 114, 107–113 (2001).
   Google Scholar
• Lynch JR, Wang H, Mace B et al. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp. Neurol. 192, 109–116 (2005).
   Google Scholar
• Tukhovskaya EA, Yukin AY, Khokhlova ON, Murashev AN, Vitek MP. COG1410, a novel apolipoprotein-E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia. J. Neurosci. Res. 87, 677–682 (2009).
   Google Scholar